We are monitoring the impact of COVID-19 on MEA Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Plasma Fractionation Market Research Report – Segmented By Product, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVId-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2724
Pages: 145

MEA Plasma Fractionation Market Size (2022 to 2027)

The size of the plasma fractionation market in the Middle East & Africa is estimated to be USD 2.32 billion in 2022. It is projected to be growing at a CAGR of 4.02% and worth USD 2.82 billion by 2027.

Plasma is the liquid portion of blood that consists of red cells, white cells, and platelets suspended in it and also contains thousands of various proteins and other substances like electrolytes, minerals, hormones, etc., which are necessary for the normal function of the human body.

Plasma Fractionation is the fractionation of blood into its constituent parts of red cells, white cells, and platelets, suspended in plasma. The plasma is studied for deficiencies relating to blood disorders and replaced or supplemented with a cure. Maintenance of blood pressure and the regulation of body temperature is among the vital functions of Plasma.

The growth of the Middle East and Africa Plasma Fractionation Market is mainly driven by the increasing occurrence of bleeding and immunity disorders related to blood, the rising use of albumin and immunoglobulins, and the growing aging population.

High costs of plasma products and the side-effects of plasma fractionation & plasma exchange are among the factors that hinder the growth of the Middle East and Africa plasma fractionation market.

This research report on the MEA plasma fractionation market has been segmented and sub-segmented into the following categories:

By Product: 

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Protease Inhibitors

By Application: 

  • Neurology
  • Hematology
  • Rheumatology
  • Pulmonology
  • Immunology

By End User: 

  • Hospitals
  • Clinical Laboratories

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

Some of the companies playing a key role in the MEA plasma fractionation market profiled in the report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Immunoglobulin Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Coagulation Factor Concentrates Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Albumin Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Protease Inhibitors Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Other Plasma Products Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Neurology Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Immunology Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Hematology Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Critical Care Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Pulmonology Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Hemato-oncology Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Rheumatology Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Other Applications Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Clinical Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle East & Africa Academic Institutes Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  21. Middle East Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  22. Middle East Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)
  23. Africa Plasma Fractionation Market, By Product, From 2022 - 2027 (USD Million)
  24. Africa Plasma Fractionation Market, By Application, From 2022 - 2027 (USD Million)
  25. Africa Plasma Fractionation Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample